Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dewi Shri Farmindo Tbk. (DEWI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Dewi Shri Farmindo Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Dewi Shri Farmindo Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Dewi Shri Farmindo Tbk. trades at Rp139 (market cap 280B, 63.3M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.3× Dewi Shri Farmindo Tbk.'s market cap, and Dewi Shri Farmindo Tbk. is more actively traded (63.3M versus 843K). Which is the better fit depends on your goals.

DEWILABS
Market Cap
280B635.95B
Volume
63.3M843K
Lot
632.99K8.43K
Turnover
8.85B137.6M
Average Price
139.84163.22
Value
8.85B137.6M
Indicative Equilibrium Price
139165
Indicative Equilibrium Volume
11.34K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DEWI
View details
LABS
View details

About Dewi Shri Farmindo Tbk.

PT Dewi Shri Farmindo Tbk (The "Company") is domiciled in Cianjur was established based on notarial deed No. 15 dated September 17, 2019 of Amaliyah, S.H.,M.Kn notary in Jakarta. The Company commenced commercial operations in 2019.

Read more on DEWI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS